Flagship Harbor Advisors, LLC Beam Therapeutics Inc. Transaction History

Flagship Harbor Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$64.12 - $128.71 $230,190 - $462,068	-3,590 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$71.28 - $120.75 $41,698 - $70,638	585 Added 19.47%	3,590 $287,000
Q4 2020 Feb 08, 2021	BUY	$22.24 - $95.63 $3,447 - $14,822	155 Added 5.44%	3,005 $245,000
Q1 2020 May 12, 2020	BUY	$13.31 - $29.2 $37,933 - $83,220	2,850 New	2,850 $51,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $2.04B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.